Cross-fund · 5 holders
XENE
XENON PHARMACEUTICALS INC
CUSIP 98420N105
5
Tracked holders
$538.4M
Aggregate value
9,411,534
Shares
5
Active funds
Funds holding XENE
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $328.0M | 0.01% | +539,834 | +10.6% |
| Citadel | Multi-Strategy | Q1 2026 | $167.8M | 0.03% | +1,456,677 | +101.9% |
| Vanguard | Institutional | Q4 2025 | $29.8M | — | -186,745 | -21.9% |
| Millennium | Multi-Strategy | Q1 2026 | $11.7M | — | -433,271 | -68.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.1M | — | 0 | HELD |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.